A review study on the present and novel treatments for metabolic disorder

Omonova Gavhar Sultonovna 1, Shagufta kalim Khan 1, Mohammad Faizan 2, Muhammad Arsalan Ali Sajid 2, * and Kurbanniyozova Yulduz Allaberganovna 3

1 Department of pharmacology and clinical pharmacology at Urgench Branch of Tashkent Medial Academy, Urgench, Uzbekistan.
2 Faculty of General Medicine, Urgench Branch of Tashkent Medial Academy, Urgench, Uzbekistan.
2 Faculty of General Medicine, University of Sargodha, Urgench branch of Tashkent Medical Academy, Uzbekistan, Health Management, IUBH University, Germany.
3 Department of Pharmacology, Urgench Branch of Tashkent Medical Academy, Uzbekistan.
 
Review Article
World Journal of Advanced Research and Reviews, 2023, 18(02), 1299–1304
Article DOI: 10.30574/wjarr.2023.18.2.0911
 
Publication history: 
Received on 08 April 2023; revised on 18 May 2023; accepted on 21 May 2023
 
Abstract: 
Metabolic syndrome is the most common issue faced by a large population, especially women and old aged people. This is not only a clinical issue for the women and adults but also a social concern particularly among children and adolescents in high-income areas. The prevention and
Cure are the hottest area of discussion through the years and many recommendations came regarding preventions and treatments as depressing the asprosin hormone level which is a major cause of high appetite and increase sugar level in blood can help in controlling the obesity and few metabolisms, and nutraceuticals discoveries. There are few proposals about adding psychological interventions in treatments, as these people should also be motivated psychologically as these people sometimes these people face social isolation and give up on treatments. In the SARS-COV 2 pandemic the incidences of this syndrome due to restricted movement of people and other factors.
 
Keywords: 
Novel treatments; Metabolic Treatments; Asprosin Hormone; Adolescent; Metabolomics
 
Full text article in PDF: 
Share this